Dyne Therapeutics Files 8-K with Material Agreement Details

Ticker: DYN · Form: 8-K · Filed: Jul 1, 2025 · CIK: 1818794

Dyne Therapeutics, INC. 8-K Filing Summary
FieldDetail
CompanyDyne Therapeutics, INC. (DYN)
Form Type8-K
Filed DateJul 1, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, filing

TL;DR

Dyne Therapeutics filed an 8-K on 6/30/25 detailing a material definitive agreement.

AI Summary

On June 30, 2025, Dyne Therapeutics, Inc. filed an 8-K report detailing a material definitive agreement. The filing also included other events and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 1560 Trapelo Road, Waltham, Massachusetts.

Why It Matters

This filing provides crucial updates on significant agreements and financial information for Dyne Therapeutics, impacting investor understanding of the company's current status and future prospects.

Risk Assessment

Risk Level: medium — Material definitive agreements can significantly alter a company's financial and operational landscape, introducing both opportunities and risks.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement filed by Dyne Therapeutics?

The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 30, 2025.

Where are Dyne Therapeutics' principal executive offices located?

Dyne Therapeutics' principal executive offices are located at 1560 Trapelo Road, Waltham, Massachusetts.

In which state is Dyne Therapeutics incorporated?

Dyne Therapeutics is incorporated in Delaware.

What is the SIC code for Dyne Therapeutics?

The Standard Industrial Classification (SIC) code for Dyne Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on July 1, 2025 regarding Dyne Therapeutics, Inc. (DYN).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing